Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/28/1993 | WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins |
10/28/1993 | WO1993020959A1 Method and device for bioremediation |
10/28/1993 | WO1993020686A1 Plant resistant to two or more viruses and preparation thereof |
10/28/1993 | WO1993018169A3 Expression cassette and plasmids for a guard cell specific expression and their use for the introduction of transgenic plant cells and plants |
10/28/1993 | WO1993018168A3 Transgenic wheat |
10/28/1993 | WO1993018166A3 PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R) |
10/28/1993 | WO1993018154A3 Method for enhancing plant precocity and/or reducing the stored nitrate content of a plant |
10/28/1993 | WO1993013196A3 Method for increasing recombinant protein production |
10/28/1993 | DE4213444A1 Prodn. of potato plants with suppressed tuber sprouting - by genetic modification to reduce sucrose concn. |
10/28/1993 | CA2133999A1 Recombinant mutants for inducing specific immune responses |
10/28/1993 | CA2118249A1 Microwave modification of biological macromolecules |
10/28/1993 | CA2117887A1 Polysaccharide binding fusion proteins and conjugates |
10/28/1993 | CA2117747A1 A novel hyaluronan receptor protein and novel hyaluronan binding peptides |
10/28/1993 | CA2111565A1 Plants resistant against plural viruses and method for producing them |
10/27/1993 | EP0567448A1 Factor VIII preparation |
10/27/1993 | EP0567088A2 Processes for the preparation of amylase inhibitor |
10/27/1993 | EP0566897A2 The complete gene (cefG) encoding the acetyl-CoA: deacetylcephalosporin C acetyltransferase of Cephalosporium acremonium, its isolation and use |
10/27/1993 | EP0566596A1 Increased expression by a second transferred sequence in transgenic organisms |
10/27/1993 | CN1077715A Process for simultaneous renaturation and purification of denatured protein |
10/26/1993 | US5256788 Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes |
10/26/1993 | US5256770 Oxidation resistant thrombomodulin analogs |
10/26/1993 | US5256766 Recombinant thrombin receptor and related pharmaceuticals |
10/26/1993 | US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
10/26/1993 | US5256558 Gene encoding plant asparagine synthetase |
10/26/1993 | US5256557 Incubation of mixture of alkaline protease and hydrolytic enzymes to separate protease from cells and suspended solids |
10/26/1993 | US5256556 Decomposition of yeast cells; adjustment of ph to acidic; heat trteatment; denaturing |
10/26/1993 | US5256554 Expression of human immunodeficiency virus (HIV) reverse transcriptase |
10/26/1993 | US5256551 Heat-treating Escherichia in presence of ammonium compound |
10/26/1993 | CA1323727C Glutamine-containing peptides, a process for the preparation thereof, and the use thereof |
10/22/1993 | CA2094221A1 Stable isoforms of creatine kinase for standard markers and diagnosis |
10/21/1993 | DE4209022A1 Selective sec. S-alcohol prodn. from ketone - by incubating with new microbial dehydrogenase and NADH, useful as intermediates for biologically active cpds. |
10/21/1993 | CA2091400A1 Calpain inhibitor cystamidine a and its production |
10/20/1993 | EP0566554A2 Production of recombinant proteins using herpes virus promoters and VP16 transactivators |
10/20/1993 | EP0566275A1 Trehalase inhibitor and production thereof |
10/20/1993 | EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation |
10/20/1993 | EP0566140A2 Method for producing dinucleoside polyphosphate, nucleoside polyphosphate or derivatives thereof |
10/20/1993 | EP0565626A1 Fusions of a viral protein and a destructive enzyme |
10/20/1993 | EP0565582A1 Novel csaids |
10/20/1993 | EP0506866B1 Method for crystallization of enzymes |
10/20/1993 | EP0220241B1 Purified protein having angiogenic activity and methods of preparation |
10/20/1993 | CN1077390A Thrombolyzing medicine and its prepn. |
10/19/1993 | US5254801 Inducing male sterility for hybrid seed production, cell ablation, counter-negative selection; genetic engineering |
10/19/1993 | US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof |
10/19/1993 | US5254532 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
10/19/1993 | US5254470 Alkaline protease, alkaline protease gene, recombinant DNA, DNA fragment for the expression of gene, and process for the production of alkaline protease |
10/14/1993 | WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems |
10/14/1993 | WO1993020216A1 Oil-body protein cis-elements as regulatory signals |
10/14/1993 | WO1993020215A1 Process for producing recombinant proteins in steptomycetes |
10/14/1993 | WO1993020214A1 Heterologous gene expression in bacillus subtilis: fusion approach |
10/14/1993 | WO1993020211A1 A method of limiting the survival of genetically engineered microorganisms in their environment |
10/14/1993 | WO1993020209A1 Methods for producing substantially pure eg iii cellulase using alcohol |
10/14/1993 | WO1993020208A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
10/14/1993 | WO1993020207A1 Use of restriction endonucleases against viruses, including hiv |
10/14/1993 | WO1993020206A1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
10/14/1993 | WO1993020195A1 Method and recombinant cells for providing increased resistance of hematopoietic progenitor cells to toxicity of chemotherapeutic agents |
10/14/1993 | WO1993020194A1 Tpa analog |
10/14/1993 | WO1993020193A1 ENDO-β-1,4-GLUCANASE AND A DNA SEQUENCE |
10/14/1993 | WO1993020192A1 DELIGNIFYING PREPARATION EXHIBITING α-L-ARABINOFURANOSIDASE ACTIVITY, PRODUCTION AND APPLICATION THEREOF |
10/14/1993 | WO1993020191A1 Purified thermostable endonuclease |
10/14/1993 | WO1993020190A1 A novel enzyme and a dna sequence |
10/14/1993 | WO1993020101A1 Inhibitor of protein kinase c |
10/14/1993 | WO1993020098A1 Process for preparing modified proteins |
10/14/1993 | WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same |
10/14/1993 | WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/14/1993 | WO1993019720A2 Compounds |
10/14/1993 | WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
10/14/1993 | DE4211517A1 Verfahren zur Herstellung rekombinanter Proteine in Streptomyceten A process for the production of recombinant proteins in streptomycetes |
10/14/1993 | CA2132961A1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
10/14/1993 | CA2132624A1 Compositions and methods for regulating cellular signal transducing systems |
10/14/1993 | CA2132434A1 Endo-.beta.-1, 4-glucanase and a dna sequence |
10/14/1993 | CA2132433A1 A novel enzyme and a dna sequence |
10/14/1993 | CA2132335A1 Delignifying preparation exhibiting .alpha.-l-arabinofuranosidase activity production and application thereof |
10/14/1993 | CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/13/1993 | EP0565512A1 Method of activating blood coagulation factors |
10/13/1993 | EP0565511A1 Method of cleaving proteins |
10/13/1993 | EP0565241A1 Oligosaccharides |
10/13/1993 | EP0565172A1 Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity |
10/13/1993 | EP0565168A2 Purified enzyme concentrate and method of preparation |
10/13/1993 | EP0565135A1 Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents |
10/13/1993 | EP0564965A2 Integrative gene-expression in food-grade microorganisms |
10/13/1993 | EP0564801A1 Analysis of host cell shut-off |
10/13/1993 | EP0564539A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
10/13/1993 | EP0564524A1 Control of fruit ripening and senescence in plants |
10/13/1993 | EP0564513A1 TAPETUM-SPECIFIC PROMOTERS FROM $i(BRASSICACEAE) SPP |
10/13/1993 | EP0540687A4 Antibody-mediated cofactor-driven reactions |
10/13/1993 | CN1077224A A process for expressing polypeptide |
10/12/1993 | US5252726 Derived from Aspergillus niger neutral alpha-amylase gene |
10/12/1993 | US5252601 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
10/12/1993 | US5252571 Antidiabetic agents |
10/12/1993 | US5252481 Mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
10/12/1993 | US5252478 Thermostable mutants of neutral protease and means for their preparation |
10/12/1993 | US5252477 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
10/12/1993 | US5252476 Superoxide dismutase cloning and expression in microorganisms |
10/12/1993 | US5252474 Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
10/12/1993 | US5252470 D-amidase and process for producing D-α-alanine and/or L-α-alanineamide |
10/12/1993 | US5252469 Process for producing a transglutaminase derived from streptomyces |
10/12/1993 | US5252468 Process for producing deacetylase from Vibrio cholerea IFO 15429 |
10/12/1993 | US5252466 Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them |
10/12/1993 | US5252463 Clipsin, a chymotrypsin-like protease and method of using same |
10/12/1993 | US5252289 Water soluble 1,2-dithio-3-thiones |